Read More Pharma Industry News Positive interim ADAPT trial data place Creative Medical Technology Holdings at a critical clinical crossroads in regenerative pain care Find out how positive interim ADAPT trial data could place Creative Medical Technology Holdings at a critical inflection point in non-opioid regenerative pain treatment. bySoujanya RaviJanuary 17, 2026